JNJ news

Johnson & Johnson · end-of-day data as of Oct 16, 2026

Johnson & Johnson

JNJ · $616B

$255.56-2.5%last 60 sessions · close Oct 16, 2026

$181.90$278.4352 weeks

Buy · 23 analystsPT $278.14 +8.8%

P/E vs own+33.3%
P/E vs sector+37.6%
Target upside+8.8%
Off 52w high-8.2%
Insiders-$64.74M
FCF yield—
Earnings in96d
Trendbullish
Sector▲ +16.0%
RSI44
MA20×50Death 5d ago
Volume0.9x
Support-1.0%
Resistance+4.9%

Last session

News

Headlines

Procter & Gamble Has Raised Its Dividend for 70 Years. These 2 Stocks Share Its Advantage
24/7 Wall Street · Oct 17, 2026
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.
The Motley Fool · Oct 17, 2026
If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys
Fool - Investing News · Oct 17, 2026
Johnson & Johnson $JNJ Stock: AdvisorNet Financial Inc Increases Stake
Defense World · Oct 17, 2026
Johnson & Johnson $JNJ Position Boosted by Assenagon Asset Management S.A.
Defense World · Oct 17, 2026
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool · Oct 16, 2026
Johnson & Johnson: 3 Key Takeaways for Long-Term Investors
The Motley Fool · Oct 16, 2026
The Stocks That Will Get Investors Home Safe When Tech Cracks
24/7 Wall Street · Oct 16, 2026
Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Reuters · Oct 16, 2026
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Reuters · Oct 15, 2026
Procter & Gamble Has Raised Its Dividend for 70 Years. These 4 Stocks Also Reward Patience
24/7 Wall Street · Oct 15, 2026
Johnson & Johnson $JNJ Stock: Cliftonlarsonallen Wealth Advisors LLC Boosts Position
Defense World · Oct 15, 2026
Johnson & Johnson Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Johnson & Johnson (JNJ)
PRNewsWire · Oct 14, 2026
These Analysts Cut Their Forecasts On Johnson & Johnson After Q3 Results
Benzinga · Oct 14, 2026
The 3-Bucket Income System Making $13,000/Month in Pure Dividends
247 Wallst · Oct 14, 2026
Stock of the Day: Is this the Bottom for Johnson & Johnson?
Benzinga · Oct 14, 2026
JNJ Q3 Earnings Call Highlights Growth Outlook and MedTech Challenges
Zacks Investment Research · Oct 14, 2026
J&J Beat and Raised. The Stock Fell Anyway.
24/7 Wall Street · Oct 14, 2026
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
24/7 Wall Street · Oct 14, 2026
5,122 Johnson & Johnson $JNJ Shares Sold by Perpetual Ltd
Defense World · Oct 14, 2026
Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast
Fox Business · Oct 13, 2026
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings?
Zacks Investment Research · Oct 13, 2026
J&J raises its forecast again. CFO Joe Wolk on what's driving it
Yahoo Finance · Oct 13, 2026
Retiring at 56 on $5,950 a Month for Life: The Portfolio Size Most People Guess Wrong
247 Wallst · Oct 13, 2026
Johnson & Johnson: Keep Calm And Hold On
Seeking Alpha · Oct 13, 2026
Johnson & Johnson (JNJ) Q3 2026 Earnings Call Transcript
Seeking Alpha · Oct 13, 2026
Johnson & Johnson shares fall following earnings
CNBC Television · Oct 13, 2026
QUICK SPARK: J&J Eyes Worst Day Since April 2025 with MedTech Miss
Benzinga · Oct 13, 2026
Johnson & Johnson Q3 Earnings: Talc Resolution Offer Impacts Earnings, MedTech Slows Growth
Seeking Alpha · Oct 13, 2026
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
MarketBeat · Oct 13, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.